oral semaglutide news improves blood sugar, weight, and liver markers in real-world diabetes care Dr Reddy's Launches Oral Semaglutide

Also, a small non-randomized study 15 in two older adults treated with ALC (2 g/day for 12 weeks), reported a decrease in HDRS scores from 15 to 0 and from 20 to 3 by week 12 and compared outcomes with six non-depressed controls

The important thing is that the trajectory is established

If you want more detailed guidance on protein intake while taking GLP-1 medications, our muscle and protein planner provides it

Real-world evidence from UK and European databases suggests that patients with type 2 diabetes and fatty liver who receive GLP-1 therapy experience improvements in liver enzyme levels (ALT, AST) and non-invasive markers of fibrosis

From the perspective of prolactin: a view on obesity

Jonathan I